Literature DB >> 17704982

[Pelargonium sidoides-extract (EPs 7630): registration confirms efficacy and safety].

Andreas Conrad1, Herbert Kolodziej, Volker Schulz.   

Abstract

For centuries the roots of Pelargonium sidoides DC have been used in South African ethno-medicine for the treatment of respiratory diseases. In Germany, a medicinal product containing a special extract of this substance is among the group of self-medication products most widely bought at chemist's shops. In December 2005, the Federal Institute for Drugs and Medical Devices (BfArM, Bonn) approved a new license for its use as a drug. The following review focuses on the current pharmacological, toxicological and clinical data covering the efficacy and innocuousness of this drug when administered for the treatment of acute bronchitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17704982     DOI: 10.1007/s10354-007-0434-6

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  18 in total

1.  Pharmacological profile of extracts of Pelargonium sidoides and their constituents.

Authors:  Herbert Kolodziej; Oliver Kayser; Oliver A Radtke; Albrecht F Kiderlen; Egon Koch
Journal:  Phytomedicine       Date:  2003       Impact factor: 5.340

2.  Mass spectroscopic characterisation of oligomeric proanthocyanidins derived from an extract of Pelargonium sidoides roots (EPs 7630) and pharmacological screening in CNS models.

Authors:  Karl Schötz; Michael Nöldner
Journal:  Phytomedicine       Date:  2007-01-10       Impact factor: 5.340

3.  Treatment of acute bronchitis in adults with a pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial.

Authors:  A G Chuchalin; B Berman; W Lehmacher
Journal:  Explore (NY)       Date:  2005-11       Impact factor: 1.775

4.  Treatment effect and safety of EPs 7630-solution in acute bronchitis in childhood: report of a multicentre observational study.

Authors:  M Haidvogl; M Heger
Journal:  Phytomedicine       Date:  2006-12-20       Impact factor: 5.340

5.  Extract of Pelargonium sidoides (EPs 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in vitro.

Authors:  Andreas Conrad; Cathrin Hansmann; Inge Engels; Franz D Daschner; Uwe Frank
Journal:  Phytomedicine       Date:  2006-12-20       Impact factor: 5.340

6.  Extract of Pelargonium sidoides (EPs 7630) inhibits the interactions of group A-streptococci and host epithelia in vitro.

Authors:  Andreas Conrad; Irina Jung; Diane Tioua; Caroline Lallemand; Felipe Carrapatoso; Inge Engels; Franz D Daschner; Uwe Frank
Journal:  Phytomedicine       Date:  2006-12-19       Impact factor: 5.340

Review 7.  In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs 7630.

Authors:  Herbert Kolodziej; Albrecht F Kiderlen
Journal:  Phytomedicine       Date:  2006-12-22       Impact factor: 5.340

8.  Treatment of rats with the Pelargonium sidoides extract EPs 7630 has no effect on blood coagulation parameters or on the pharmacokinetics of warfarin.

Authors:  E Koch; A Biber
Journal:  Phytomedicine       Date:  2006-12-22       Impact factor: 5.340

9.  Immunomodulatory principles of Pelargonium sidoides.

Authors:  O Kayser; H Kolodziej; A F Kiderlen
Journal:  Phytother Res       Date:  2001-03       Impact factor: 5.878

10.  Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study.

Authors:  H Matthys; M Heger
Journal:  Curr Med Res Opin       Date:  2007-02       Impact factor: 2.580

View more
  5 in total

Review 1.  Phytotherapeutic and naturopathic adjuvant therapies in otorhinolaryngology.

Authors:  Raphael Richard Ciuman
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-16       Impact factor: 2.503

Review 2.  Pelargonium sidoides extract EPs 7630: a review of its clinical efficacy and safety for treating acute respiratory tract infections in children.

Authors:  Domenico Careddu; Andrea Pettenazzo
Journal:  Int J Gen Med       Date:  2018-03-08

3.  Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses.

Authors:  Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Phytomedicine       Date:  2010-10-30       Impact factor: 5.340

4.  Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells.

Authors:  Jan Papies; Jackson Emanuel; Nicolas Heinemann; Žarko Kulić; Simon Schroeder; Beate Tenner; Martin D Lehner; Georg Seifert; Marcel A Müller
Journal:  Front Pharmacol       Date:  2021-10-25       Impact factor: 5.810

Review 5.  Traditional medicines in Africa: an appraisal of ten potent african medicinal plants.

Authors:  M Fawzi Mahomoodally
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-03       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.